BioNano Genomics Inc vs Global X Lithium & Battery Tech ETF — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Global X Lithium & Battery Tech ETF trades at $75.34. The key difference: Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | LIT | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $4.92 | $91.62 |
52-Week Low | $1.06 | $44.96 |
Enterprise Value | $16.26M | — |
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
LIT trades at $75.21, up 0.63% with a bullish technical signal supported by moving averages. The stock has doubled over the past year, driven by strong momentum in energy storage, semiconductors, and electric vehicles. Recent news highlights global EV sales growth and China's ambitious 30% NEV fleet target by 2030, providing positive sector tailwinds. However, key financial ratios remain undisclosed in current data.
The outlook remains positive given sector catalysts in EVs and energy storage, though RSI levels suggest potential near-term overbought conditions. Investment opportunities center on lithium market inflection and semiconductor demand, while risks include competitive pressures and reliance on Chinese EV policy developments. The stock's 125% return from last year's low indicates strong momentum but warrants caution at current levels.
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →